Henry Meds vs Novi: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Henry Meds beats Novi overall, scoring 8.4/10 vs 7.8/10. Novi is more affordable at $133/mo vs $199/mo. Choose Henry Meds for users seeking a well-rounded program with good pricing and m. Choose Novi for cash-pay patients who want compounded semaglutide or tirzepa.
A side-by-side comparison of Henry Meds and Novi covering pricing, scores, medication types, insurance, and more to help you decide.
Henry Meds
#6 of 46Popular telehealth platform offering a wide range of GLP-1 options with competitive pricing and reliable service.
Visit Henry MedsNovi
#14 of 46Telehealth platform for compounded semaglutide and tirzepatide with month-to-month billing, six named clinicians on staff, and a 3-minute pre-approval quiz. Novi emphasizes 'all-in transparent' pricing — medication, supplies, unlimited clinician check-ins, dose adjustments, and weight-loss coaching are bundled with no add-on fees. Standard pricing is $174/mo semaglutide and $283/mo tirzepatide; promotional pricing on the offer landing drops to $99-$133/mo semaglutide and $149-$166/mo tirzepatide with $200 off advertised.
Visit Novi| Feature | Henry Meds | Novi |
|---|---|---|
| Our Score | 8.4/10 | 7.8/10 |
| Starting Price | $199/mo | $133/mo |
| Medication Type | Both | Compounded |
| Insurance Accepted | No | No |
| Best For | Users seeking a well-rounded program with good pricing and medication variety | Cash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offer |
| Ranking | #6 | #14 |
Pros & Cons Compared
Henry Meds
Pros
- +Strong medication variety — both brand-name (Wegovy, Zepbound) and compounded options under one roof
- +$199/mo is well-priced for a platform offering both medication types with clinical support
- +Active patient community and responsive support team with typical <4 hour email response times
- +Easy medication switches — can move from compounded to brand-name (or vice versa) without re-enrollment
Cons
- −No insurance billing — $199/mo is entirely out-of-pocket, though they provide superbills
- −Consultation wait times can stretch to 3-5 days during peak periods (January, post-holiday)
Novi
Pros
- +Six disclosed clinicians on staff — Daniel Funsch MD, Michael Wasef MD, Takashi Nakamura MD plus three nurse practitioners (Hastings NP, Clements NP, Vergara DNP) — more named providers than most compounded-only platforms publish
- +Month-to-month billing with no minimum commitment — cancel before any renewal date with no early-termination penalty
- +Aggressive promotional pricing on the offer landing — $99-$133/mo compounded semaglutide and $149-$166/mo compounded tirzepatide with a $200 OFF intro discount
- +Unlimited clinician check-ins, dose adjustments, and weight-loss coaching included at no additional cost
- +Free 2-day shipping; same active ingredients as Wegovy/Ozempic and Mounjaro/Zepbound (semaglutide and tirzepatide respectively)
- +100,000+ patients claimed and editorial coverage in Bloomberg, Forbes, and WebMD provide third-party signal
Cons
- −Compounded-only — no FDA-approved Wegovy, Zepbound, Ozempic, or Mounjaro through the platform; no Foundayo or oral GLP-1 formats
- −Founding year, headquarters city, and corporate ownership are not publicly disclosed
- −Promotional $99-$133 pricing applies to the introductory offer landing only — standard rate after any qualifying intro period is $174-$283/mo (verify the renewal rate before enrolling)
- −Once medication is dispensed/shipped, prescriptions cannot be returned or refunded — typical for compounded telehealth but worth understanding
- −Lab requirements before prescribing are not disclosed on public pages — unclear whether baseline bloodwork is required
- −Multiple landing pages (offer-v4, offer-v6-low) show different headline prices, which can create pricing confusion before checkout
Our Verdict
Henry Meds edges out Novi with a score of 8.4/10 vs 7.8/10. If budget is your priority, Novi starts at $133/mo compared to Henry Meds's $199/mo. Henry Meds offers both brand-name and compounded medications, giving you more flexibility. Choose Henry Meds if you want: users seeking a well-rounded program with good pricing and medication variety. Choose Novi if you want: cash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offer.